Alvotech ( (ALVO) ) is experiencing volatility. Read on for a possible explanation for the stock’s unusual movement.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Alvotech’s stock is on the rise following an upgrade from Morgan Stanley, which highlighted the company’s consistent research and commercial progress. The firm’s diverse partnerships and recent approvals for biosimilars in Japan and Europe are seen as key factors enhancing its market outlook.
More about Alvotech
YTD Price Performance: -39.44%
Average Trading Volume: 406,198
Technical Sentiment Signal: Sell
Current Market Cap: $2.49B
For further insights into ALVO stock on TipRanks’ Stock Analysis page.
See more of today’s top stock gainers and losers.